November 18th 2024
More than half of US adults—approximately 137 million—are candidates for semaglutide based on diabetes, weight management, or cardiovascular prevention indications.
November 16th 2024
Metabolic Changes Accelerate Cognitive Decline in Type 2 Diabetics
March 3rd 2014Examining evidence from epidemiologic, clinical, and animal studies, a team of researchers discussed the connection between neural dysfunction and metabolic disorders related to type 2 diabetes in the February 2014 issue of Current Diabetes Reports.
Low Vitamin D Levels in Pregnancy Linked to Increased Gestational Diabetes Risk
February 27th 2014New study results suggest low levels of vitamin during the first trimester are a modest yet consistent and independent risk factor for developing gestational diabetes and are associated with insulin resistance at the second trimester.
Preventing the Spread of Vaccine-Preventable Disease Among Diabetic Patients
February 26th 2014While the dangers of influenza and pneumococcal pneumonia in patient with diabetes are well understood, less known is the fact that diabetics are at increased risk for contracting hepatitis B if they share blood glucose meters, finger stick devices, or other diabetes-care equipment.
Testosterone Levels Tied to Sildenafil's Success in Diabetics With Hypogonadism
February 24th 2014Similar to its effect in non-diabetic patients with low testosterone, sildenafil citrate correlates with improvements in testosterone levels and erectile function among hypogonadal men with type 2 diabetes mellitus.
Evaluating Treatments for Painful Diabetic Neuropathy
February 13th 2014Meta-analysis of clinical trial data on the use of antidepressants and anticonvulsants for the treatment of painful diabetic neuropathy indicates gabapentin is the most efficacious agent for this condition, while the side effects associated with amitriptyline make it the least tolerable treatment option evaluated in the study.
Meeting Report: World Diabetes Congress
February 3rd 2014Five presentations from the World Diabetes Congress are highlighted, covering studies of long-acting Lantus insulin, affordability of care, DPP-4 inhibitors and heart failure in diabetes, brown versus white rice to reduce obesity and diabetes, and the converging pandemics of diabetes and tuberculosis.
Increasing Protein Intake Won't Weaken Renal Function in Diabetics
January 27th 2014Until recently, it was unclear whether high-protein diets accelerate renal disease in susceptible individuals - including the roughly half of all diabetics who experience complete renal failure as a result of elevated glucose levels overworking the kidneys.
Thyroid Dysfunction Increases Cardiovascular Risks in Diabetic Dialysis Patients
January 24th 2014Though dialysis patients have a greater risk for thyroid disorders due to uremic toxins, protein malnutrition, and inflammation, the prevalence of those disorders and their impact on cardiovascular (CV) events and mortality have not been investigated.
FDA Reduces Restrictions on Diabetes Medication Rosiglitazone
November 26th 2013Following an extended review of safety data that showed no elevated risk of heart attack or death in patients taking rosiglitazone, the FDA announced it is lifting certain restrictions on the prescribing and dispensing of the drug.